Misplaced Pages

Talk:Aspartame controversy/to do

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
< Talk:Aspartame controversy

This is an old revision of this page, as edited by MaxPont (talk | contribs) at 08:49, 31 May 2009 (add timeline (it might be forgotten otherwise). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 08:49, 31 May 2009 by MaxPont (talk | contribs) (add timeline (it might be forgotten otherwise)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Here are some tasks awaiting attention:
  • Cleanup : Scientific publications -- weak Gone --SV Resolution(Talk) 15:29, 30 April 2009 (UTC) Alleged conflict of intrerest prior to 1996 -- should this be merged into discussion of approval?
  • Expand : Why the US approval process caused controversy
    • Charges of COI in DOJ handling of FDA's Fraud allegations against Searle.
    • Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum)
    • Studies by Olney and others dismissed.
    • Expand and integrate the timeline in the article
    • Charges of COI when new FDA commissioner overturned unanimous decision of PBOI
    Senator Metzenbaum's role in returning the controversy to the news. Why the Ramazzinni studies contribute to the controversy
    • Allegations of COI in industry-funded critiques of Soffritti studies
    ...
  • NPOV : Remember that some parts of this article follow WP:MEDRS and must reflect the preponderance of medical opinion, while other parts of this article follow WP:CONTROVERSY and must explain the controversy.
  • Verify : Different types of sources are appropriate to different sections of this article.